After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google is consolidating its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind.

Google announced that it will consolidate some of its teams focused on developing artificial intelligence (AI) models within the Google DeepMind unit, which was created last year.

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Historically, DeepMind and Google Brain pursued research projects separately. Indeed, DeepMind reported has been at odd with Google’s AI researchers in recent years.

Alphabet's Google has consolidated its artificial intelligence research groups into one unit, the company's latest move to keep from falling behind in the AI race.

MedPaLM is a promising language model in the medical field so far. Google Research and DeepMind have launched an AI-based healthcare platform called MedPaLM, as reported by Interesting Engineering.

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google ...

DeepMind, Alphabet’s (GOOGL) AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in the fast-evolving AI sector, the Financial Times ...